From the clinician's point of view-What is the status quo of positron emission tomography in patients with brain tumors?

N Galldiks, KJ Langen, WB Pope - Neuro-oncology, 2015 - academic.oup.com
The most common type of primary brain tumor is malignant glioma. Despite intensive
therapeutic efforts, the majority of these neoplasms remain incurable. Imaging techniques …

[PDF][PDF] Current radiopharmaceuticals for positron emission tomography of brain tumors

J Jung, BC Ahn - Brain tumor research and treatment, 2018 - synapse.koreamed.org
Brain tumors represent a diverse spectrum of histology, biology, prognosis, and treatment
options. Although MRI remains the gold standard for morphological tumor characterization …

Applications of positron emission tomography in neuro-oncology: a clinical approach

AK Demetriades, AC Almeida, RS Bhangoo… - the surgeon, 2014 - Elsevier
The field of neuro-oncology is concerned with some of the most challenging and difficult to
treat conditions in medicine. Despite modern therapies patients diagnosed with primary …

PET Imaging in glioblastoma: Use in clinical practice

A Verger, KJ Langen - Exon Publications, 2017 - exonpublications.com
Positron emission tomography (PET) is a nuclear medicine imaging method with increasing
relevance for the diagnosis, prognostication, and monitoring of glioblastomas. PET provides …

What does PET imaging bring to neuro-oncology in 2022? a review

JT Zhang-Yin, A Girard, M Bertaux - Cancers, 2022 - mdpi.com
Simple Summary Positron emission tomography (PET) imaging is increasingly used to
supplement MRI in the management of patient with brain tumors. In this article, we provide a …

Amino acid PET in neurooncology

N Galldiks, P Lohmann, GR Fink… - Journal of Nuclear …, 2023 - Soc Nuclear Med
For decades, several amino acid PET tracers have been used to optimize diagnostics in
patients with brain tumors. In clinical routine, the most important clinical indications for amino …

Contribution of different positron emission tomography tracers in glioma management: focus on glioblastoma

A Moreau, O Febvey, T Mognetti, D Frappaz… - Frontiers in …, 2019 - frontiersin.org
Although rare, glioblastomas account for the majority of primary brain lesions, with a
dreadful prognosis. Magnetic resonance imaging (MRI) is currently the imaging method …

[PDF][PDF] Applications of PET imaging of neurological tumors with radiolabeled amino acids

N Galldiks, KJ Langen - The Quarterly Journal of Nuclear Medicine …, 2015 - researchgate.net
Routine diagnostics and treatment monitoring of brain tumors is usually based on contrast-
enhanced magnetic resonance imaging (MRI). However, the capacity of structural MRI to …

Imaging of amino acid transport in brain tumours: positron emission tomography with O-(2-[18F] fluoroethyl)-L-tyrosine (FET)

KJ Langen, G Stoffels, C Filss, A Heinzel, C Stegmayr… - Methods, 2017 - Elsevier
The assessment of cerebral gliomas using magnetic resonance imaging (MRI) provides
excellent structural images but cannot solve all diagnostic problems satisfactorily. The …

Amino acid PET–an imaging option to identify treatment response, posttherapeutic effects, and tumor recurrence?

N Galldiks, KJ Langen - Frontiers in neurology, 2016 - frontiersin.org
Routine diagnostics and treatment monitoring in patients with primary and secondary brain
tumors is usually based on contrast-enhanced standard MRI. However, the capacity of …